Unfounded fears fuel plan for FDI cap in Indian pharma
You must be signed in to read this analysis
In this article
- Foreign presence
- Misplaced concerns
- Cartelisation
- Drug prices
- Public awareness
- Generics market
- Indian overseas M&A activity
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.